The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Placing incoming maybe 🤔
Correct, hence why they refer to it as a death spiral
That would be an absolute disaster and the last thing you would hope for.
Sold out for a massive loss at 25p. Thank goodness I bit the bullet on this pile of sh*t#
You saw the pump, now comes the dump
No
Feels like someone is accumulating. Lots of large late trades over the past week. I would wager we will see a lot more again this week.
Hopefully takeover by big pharma with resources to fast track these life saving treatments. The sooner the better
I agree with your sentiment. The only thing that’s going to turn the corner, is a big discovery outside of Hav, or some corporate action around Hav, or we wait for the updated MRE and DTM in 2024
I’d hazard a guess the initial feedback hasn’t been great, based on this comment;
3DBT will continue its product development programme for City-Mix™ with a particular focus on improving the thickness and density of each end product. This is in order to address key objectives for its respective markets, including enhancing the taste and texture of cultivated meat products and developing the thickness and size of its cultivated leather products.
Listed feb 2000 and shares rose 5000% i a week. Would love to know how much money has been raised in total over that time. What a dog.
Worse than a dog. don't waste your money folks.
That didn’t age well
Lovely old pump and dump going on here
A quick read tells me enough. I won’t be investing
I think there's been plenty of supply to soak up the buying over the last few days. My guess would be Gervaise Heddle. He has previous form for ramping, whilst selling into a rise (GGP). I think this is a 10 bagger, easily. Just need to see progress with further contracts, orders, revenues, profits etc. I will buy more if it dips.
If LeakBot achieve the same results across the Länsförsäkringar Group, then the total opportunity is worth over £30 million of revenue.
As I said, no guaranteed revenue. I am very bullish about this company, but let's not start making claims that are completely untrue.
There is no guaranteed revenue from this contract?
I agree the share price to NAV looks crazy cheap and I’m tempted to take some at this level. My only concerns are around future funding requirements and how much dilution with such poor share price. Also, there’s the possibility that they could move to delist from AIM if the share price continues to underperform. I guess it’s worth a small punt.
I think most likely scenario is a delisting, so tread with care.